Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rivka Inzelberg

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Neurobiology of Aging|June 8, 2012
Identification of Alzheimer disease-associated variants in genes that regulate retromer functionBadri N Vardarajan, Sophia Y Bruesegem, Michael E Harbour, et al.
Current Alzheimer Research|November 3, 2012
Prayer at midlife is associated with reduced risk of cognitive decline in Arabic womenRivka Inzelberg, Anne E Afgin, Magda Massarwa, et al.
Journal of Molecular Neuroscience : MN|October 7, 2014
The melanocortin 1 receptor (Mc1r) variants do not account for the co-occurrence of Parkinson's disease and malignant melanomaSandra Elincx-Benizri, Rivka Inzelberg, Lior Greenbaum, et al.
Journal of Alzheimer'S Disease : JAD|November 25, 2010
Identification of novel candidate genes for Alzheimer's disease by autozygosity mapping using genome wide SNP dataRichard Sherva, Clinton T Baldwin, Rivka Inzelberg, et al.
Journal of Molecular Neuroscience : MN|March 18, 2014
Sequence variants in SLC6A3, DRD2, and BDNF genes and time to levodopa-induced dyskinesias in Parkinson's diseaseNatalie Kaplan, Aya Vituri, Amos D Korczyn, et al.
Journal of Molecular Neuroscience : MN|May 14, 2013
Do tardive dyskinesia and L-dopa induced dyskinesia share common genetic risk factors? An exploratory studyLior Greenbaum, Stefano Goldwurm, Polina Zozulinsky, et al.
Parkinsonism & Related Disorders|August 13, 2013
The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's diseaseLior Greenbaum, Simon D Israeli-Korn, Oren S Cohen, et al.
JAMA Neurology|November 18, 2014
Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysisIlir Agalliu, Marta San Luciano, Anat Mirelman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 4, 2010
Healthy aging and preclinical dementia: the United States-Israel Longitudinal Database projectAra S Khachaturian, Joab Chapman, Lindsay Farrer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 20, 2006
Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countriesHiroyuki Tomiyama, Yuanzhe Li, Manabu Funayama, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Neurobiology of Aging|June 8, 2012
Identification of Alzheimer disease-associated variants in genes that regulate retromer functionBadri N Vardarajan, Sophia Y Bruesegem, Michael E Harbour, et al.
Current Alzheimer Research|November 3, 2012
Prayer at midlife is associated with reduced risk of cognitive decline in Arabic womenRivka Inzelberg, Anne E Afgin, Magda Massarwa, et al.
Journal of Molecular Neuroscience : MN|October 7, 2014
The melanocortin 1 receptor (Mc1r) variants do not account for the co-occurrence of Parkinson's disease and malignant melanomaSandra Elincx-Benizri, Rivka Inzelberg, Lior Greenbaum, et al.
Journal of Alzheimer'S Disease : JAD|November 25, 2010
Identification of novel candidate genes for Alzheimer's disease by autozygosity mapping using genome wide SNP dataRichard Sherva, Clinton T Baldwin, Rivka Inzelberg, et al.
Journal of Molecular Neuroscience : MN|March 18, 2014
Sequence variants in SLC6A3, DRD2, and BDNF genes and time to levodopa-induced dyskinesias in Parkinson's diseaseNatalie Kaplan, Aya Vituri, Amos D Korczyn, et al.
Journal of Molecular Neuroscience : MN|May 14, 2013
Do tardive dyskinesia and L-dopa induced dyskinesia share common genetic risk factors? An exploratory studyLior Greenbaum, Stefano Goldwurm, Polina Zozulinsky, et al.
Parkinsonism & Related Disorders|August 13, 2013
The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's diseaseLior Greenbaum, Simon D Israeli-Korn, Oren S Cohen, et al.
JAMA Neurology|November 18, 2014
Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysisIlir Agalliu, Marta San Luciano, Anat Mirelman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 4, 2010
Healthy aging and preclinical dementia: the United States-Israel Longitudinal Database projectAra S Khachaturian, Joab Chapman, Lindsay Farrer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 20, 2006
Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countriesHiroyuki Tomiyama, Yuanzhe Li, Manabu Funayama, et al.
Pageof 8